Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2730) 2730
science & technology (1919) 1919
life sciences & biomedicine (1906) 1906
female (1471) 1471
male (1266) 1266
adult (1015) 1015
angioedema (970) 970
middle aged (927) 927
angioedema - drug therapy (894) 894
immunology (767) 767
angioedema - chemically induced (762) 762
allergy (742) 742
aged (585) 585
biological and medical sciences (562) 562
medical sciences (558) 558
angioneurotic edema (529) 529
angioedema - diagnosis (445) 445
angiotensin-converting enzyme inhibitors - adverse effects (439) 439
hereditary angioedema (438) 438
adolescent (416) 416
abridged index medicus (388) 388
angioedema - etiology (374) 374
angioedemas, hereditary - drug therapy (371) 371
angioedema - genetics (359) 359
treatment outcome (333) 333
child (330) 330
urticaria (329) 329
immunopathology (297) 297
general & internal medicine (296) 296
medicine, general & internal (282) 282
allergic diseases (280) 280
dermatology (272) 272
patients (270) 270
skin allergic diseases. stinging insect allergies (256) 256
bradykinin (247) 247
diagnosis, differential (247) 247
angioedema - therapy (235) 235
allergy and immunology (234) 234
drug therapy (234) 234
urticaria - drug therapy (228) 228
complement c1 inhibitor protein - therapeutic use (216) 216
angioedema - immunology (207) 207
danazol - therapeutic use (206) 206
risk factors (202) 202
young adult (199) 199
pharmacology. drug treatments (190) 190
bradykinin - analogs & derivatives (188) 188
pharmacology & pharmacy (184) 184
care and treatment (176) 176
angioedema - complications (175) 175
chronic disease (173) 173
internal medicine (171) 171
edema (164) 164
hypertension - drug therapy (164) 164
retrospective studies (163) 163
animals (150) 150
complement c1 inactivator proteins - therapeutic use (148) 148
bradykinin - therapeutic use (147) 147
complement c1 inactivator proteins - deficiency (147) 147
child, preschool (146) 146
urticaria - etiology (145) 145
medicine & public health (144) 144
aged, 80 and over (143) 143
enzymes (143) 143
angioedemas, hereditary - diagnosis (142) 142
time factors (142) 142
angiotensin-converting enzyme inhibitors - therapeutic use (141) 141
urticaria - diagnosis (140) 140
ace inhibitors (139) 139
acute disease (138) 138
angioedema - physiopathology (135) 135
histamine h1 antagonists - therapeutic use (134) 134
fundamental and applied biological sciences. psychology (131) 131
allergies (128) 128
quality of life (128) 128
diagnosis (126) 126
recurrence (124) 124
anaphylaxis (122) 122
c1 inhibitor (118) 118
complement c1 inhibitor protein (115) 115
angioedema - epidemiology (114) 114
fundamental immunology (114) 114
icatibant (113) 113
drug toxicity and drugs side effects treatment (110) 110
pediatrics (108) 108
research (107) 107
angioedema - pathology (106) 106
asthma (106) 106
mutation (104) 104
plasma (103) 103
pregnancy (100) 100
angiotensin-converting enzyme inhibitors (96) 96
antihistamines (96) 96
sarcoidosis. granulomatous diseases of unproved etiology. connective tissue diseases. elastic tissue diseases. vasculitis (96) 96
analysis (95) 95
urticaria - chemically induced (95) 95
drug hypersensitivity - etiology (94) 94
angiotensin (93) 93
health aspects (91) 91
hypersensitivity (91) 91
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2864) 2864
German (134) 134
French (115) 115
Spanish (66) 66
Japanese (20) 20
Polish (20) 20
Italian (17) 17
Russian (15) 15
Danish (11) 11
Portuguese (11) 11
Dutch (10) 10
Norwegian (7) 7
Croatian (5) 5
Hungarian (5) 5
Hebrew (4) 4
Romanian (4) 4
Chinese (3) 3
Finnish (3) 3
Korean (3) 3
Swedish (3) 3
Serbian (2) 2
Afrikaans (1) 1
Bosnian (1) 1
Czech (1) 1
Lithuanian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Advances in drug allergy, urticaria, angioedema, and anaphylaxis in 2018
by Miller, Rachel L and Shtessel, Maria and Robinson, Lacey B and Banerji, Aleena
Journal of allergy and clinical immunology, ISSN 0091-6749, 08/2019, Volume 144, Issue 2, pp. 381 - 392
angioedema | anaphylaxis | urticaria | Drug allergy | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Hypersensitivity, Delayed - pathology | Angioedema - pathology | Humans | Urticaria - pathology | Anaphylaxis - therapy | Urticaria - immunology | Hypersensitivity, Delayed - therapy | Angioedema - immunology | Hypersensitivity, Delayed - immunology | Drug Hypersensitivity - therapy | Urticaria - therapy | Drug Hypersensitivity - pathology | Anaphylaxis - chemically induced | Angioedema - therapy | Drug Hypersensitivity - immunology | Hypersensitivity, Delayed - chemically induced | Urticaria - chemically induced | Anaphylaxis - immunology | Quality of Life | beta-Lactams - adverse effects | Angioedema - chemically induced | beta-Lactams - therapeutic use | Epinephrine | Tyrosine | Drug resistance in microorganisms | C-reactive protein | Medical societies | Medical records | Epidemiology | Angioneurotic edema | Anaphylaxis | Algorithms | Beta lactamases | Drug therapy | Pediatrics | Hypersensitivity (delayed) | Pathogenesis | Clinical trials | Amides | Pruritus | Dermatitis | Antibiotic resistance | Penicillin | Hospital costs | β-Lactam antibiotics | Urticaria | Mortality | Angioedema | Hypersensitivity | Cloning | Staphylococcus infections | Patients | Quality of life | Studies | Prescription drugs | Health care expenditures | Antibiotics | MicroRNAs | Biomarkers | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug–related urticaria and angioedema
by Kowalski, Marek L., MD, PhD and Woessner, Katharine, MD, PhD and Sanak, Marek, MD, PhD
Journal of allergy and clinical immunology, ISSN 0091-6749, 2015, Volume 136, Issue 2, pp. 245 - 251
Allergy and Immunology | nonsteroidal anti-inflammatory drugs | angioedema | Aspirin | urticaria | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Drug Hypersensitivity - etiology | Humans | Drug Hypersensitivity - drug therapy | Angioedema - immunology | Angioedema - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Time Factors | Aspirin - adverse effects | Drug Hypersensitivity - immunology | Drug Hypersensitivity - diagnosis | Angioedema - chemically induced | Angioedema - diagnosis | Disease Management | Cyclooxygenase Inhibitors - therapeutic use | Skin - drug effects | Skin - pathology | Desensitization, Immunologic - methods | Skin - immunology | COX-2 inhibitors | Medical colleges | Angioneurotic edema | Diagnosis | Drug therapy | Enzymes | Acids | Pathogenesis | Classification | Nonsteroidal anti-inflammatory drugs | Kinases | Drug dosages | Patients | Allergies | Asthma | Chronic illnesses | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
by Yusuf, Salim and Teo, Koon K and Pogue, Janice and Dyal, Leanne and Copland, Ingrid and Schumacher, Helmut and Dagenais, Gilles and Sleight, Peter and Anderson, Craig and The ONTARGET Investigators and ONTARGET Investigators and Naturvetenskapliga fakulteten and Faculty of Sciences and Göteborgs universitet and Institutionen för cell- och molekylärbiologi and Gothenburg University and Department of Cell and Molecular Biology and Sahlgrenska Academy and Sahlgrenska akademin and Institutionen för medicin, avdelningen för akut och kardiovaskulär medicin and Institute of Medicine, Department of Emergeny and Cardiovascular Medicine
The New England journal of medicine, ISSN 0028-4793, 04/2008, Volume 358, Issue 15, pp. 1547 - 1559
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Male | Risk | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Benzimidazoles - therapeutic use | Double-Blind Method | Diabetes Mellitus - drug therapy | Kaplan-Meier Estimate | Hospitalization | Creatinine - blood | Angioedema - chemically induced | Aged | Complications and side effects | Ramipril | Drug therapy, Combination | Diabetes | Cardiovascular diseases | Drug therapy | Comparative analysis | Risk factors | Telmisartan | Clinical trials | Vein & artery diseases | Cardiovascular disease | Pharmacology | Clinical outcomes | Index Medicus | Abridged Index Medicus | Blood Pressure | Benzimidazoles | Cardiovascular Diseases | MEDICIN OCH HÄLSOVETENSKAP | Angiotensin II Type 1 Receptor Blockers | epidemiology | Angiotensin-Converting Enzyme Inhibitors | Combination | MEDICAL AND HEALTH SCIENCES | Creatinine | chemically induced | Benzoates | drug therapy | Angioedema | drug effects | Diabetes Mellitus | blood | adverse effects | mortality | therapeutic use | Kaplan-Meiers Estimate
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Omalizumab, an anti-immunoglobulin E antibody: State of the art
by Incorvaia, Cristoforo and Mauro, Marina and Russello, Marina and Formigoni, Chiara and Riario-Sforza, Gian Galeazzo and Ridolo, Erminia
Drug design, development and therapy, ISSN 1177-8881, 02/2014, Volume 8, pp. 197 - 207
Mastocytosis | Anaphylaxis | Anti-IgE | Atopic dermatitis | Urticaria | Hypersensitivity | Immunoglobulin E | Omalizumab | Asthma | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Off-Label Use | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Skin Diseases - drug therapy | Food Hypersensitivity - drug therapy | Nasal Polyps - drug therapy | Antibodies, Anti-Idiotypic - therapeutic use | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Asthma - drug therapy | Rhinitis, Allergic - drug therapy | Pharmaceutical research | Physiological aspects | Research | Drug therapy | Allergens | Disease | Rhinitis | Disorders | Clinical trials | Antibodies | Effector cells | Allergic bronchopulmonary aspergillosis | Dermatitis | Marketing | Immunotherapy | Drug dosages | Economics | Immunoglobulins | Angioedema | Pharmacology | Polyposis | Patients | Latex | Allergies | Aspergillosis | Monoclonal antibodies | Index Medicus | anti-IgE | hypersensitivity | mastocytosis | urticaria | atopic dermatitis | omalizumab | asthma | anaphylaxis | immunoglobulin E
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text C1 inhibitor, a multi-functional serine protease inhibitor
by A. E. Davis and F. Lu and P. Mejia
Thrombosis and haemostasis, ISSN 0340-6245, 11/2010, Volume 104, Issue 5, pp. 886 - 893
kallikrein-kinin system | C1 inhibitor | ischaemia | complement | sepsis | Reperfusion injury | Theme Issue Article | Sepsis | Complement | Kallikrein-kinin system | Ischaemia- reperfusion injury | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Hematologic and hematopoietic diseases | Biological and medical sciences | Blood coagulation. Blood cells | Molecular and cellular biology | Medical sciences | Platelet diseases and coagulopathies | Complement C1 Inhibitor Protein - therapeutic use | Capillary Permeability | Complement Activation | Humans | Reperfusion Injury - drug therapy | Structure-Activity Relationship | Shock, Septic - immunology | Reperfusion Injury - blood | Sepsis - drug therapy | Hemostasis | Shock, Septic - blood | Shock, Septic - drug therapy | Anti-Inflammatory Agents - therapeutic use | Angioedemas, Hereditary - drug therapy | Complement C1 Inhibitor Protein - metabolism | Angioedemas, Hereditary - blood | Graft Rejection - drug therapy | Sepsis - immunology | Signal Transduction | Malaria - immunology | Complement C1 Inhibitor Protein - genetics | Complement C1 Inhibitor Protein - chemistry | Angioedemas, Hereditary - immunology | Animals | Reperfusion Injury - immunology | Protein Conformation | Sepsis - blood | Graft Rejection - immunology | Malaria - drug therapy | Graft Rejection - blood | Malaria - blood
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Therapeutic peptides
by Albericio, Fernando and Kruger, Hendrik G
Future medicinal chemistry, ISSN 1756-8919, 08/2012, Volume 4, Issue 12, pp. 1527 - 1531
Lymphoma - drug therapy | Peptides - chemistry | Bacterial Infections - drug therapy | Humans | Drug Design | Drug Approval | Prodrugs - chemistry | Prodrugs - therapeutic use | Angioedemas, Hereditary - drug therapy | Peptides - therapeutic use | RNA Virus Infections - drug therapy
Journal Article
Details down arrow
7. Full Text Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
by Veerdonk, F.L. van de and Netea, M.G and Deuren, M. van and Meer, J.W.M. van der and Mast, Q. de and Bruggemann, R.J.M and Hoeven, H. van der
eLife, ISSN 2050-084X, 2020, Volume 9
Biology | Life Sciences & Biomedicine - Other Topics | Life Sciences & Biomedicine | Science & Technology | Inflammation - pathology | Pandemics | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Angioedema - metabolism | COVID-19 | Pneumonia, Viral - metabolism | Respiratory Distress Syndrome - prevention & control | SARS-CoV-2 | Coronavirus Infections - metabolism | Betacoronavirus - physiology | Anti-Inflammatory Agents - therapeutic use | Respiratory Distress Syndrome - drug therapy | Lung - metabolism | Kinins - metabolism | Lung - pathology | Angioedema - pathology | Signal Transduction | Antiviral Agents - therapeutic use | Endothelial Cells - metabolism | Pneumonia, Viral - pathology | Inflammation - immunology | Respiratory Distress Syndrome - pathology | Angioedema - drug therapy | Coronavirus Infections - pathology | Receptor, Bradykinin B2 - metabolism | Receptor, Bradykinin B1 - metabolism | Drug Development | Endothelial Cells - pathology | Bradykinin Receptor Antagonists - therapeutic use | Kallikreins - metabolism | Plasma | Ventilators | Edema | Pathogenesis | Angioedema | Lung diseases | Kallikrein | Inflammation | Permeability | Coronaviruses | Anti-inflammatory agents | Endothelial cells | Severe acute respiratory syndrome coronavirus 2 | Dyspnea | Respiratory distress syndrome | Influenza | Bradykinin | Plasma kallikrein | Ligands | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke
by Simao, Fabricio and Ustunkaya, Tuna and Clermont, Allen C and Feener, Edward P
Blood, ISSN 0006-4971, 04/2017, Volume 129, Issue 16, pp. 2280 - 2290
Life Sciences & Biomedicine | Hematology | Science & Technology | Plasma Kallikrein - metabolism | Humans | Male | Cerebral Hemorrhage - genetics | Stroke - genetics | Tissue Plasminogen Activator - adverse effects | Cerebral Hemorrhage - blood | Stroke - pathology | Fibrinolytic Agents - adverse effects | Plasma Kallikrein - genetics | Matrix Metalloproteinase 9 - metabolism | Matrix Metalloproteinase 9 - genetics | Infarction, Middle Cerebral Artery - genetics | Infarction, Middle Cerebral Artery - drug therapy | Thrombosis - blood | Disease Models, Animal | Cerebral Hemorrhage - chemically induced | Gene Expression | Factor XII - genetics | Stroke - drug therapy | Infarction, Middle Cerebral Artery - pathology | Angioedema - genetics | Infarction, Middle Cerebral Artery - blood | Mice, Knockout | Stroke - blood | Thrombosis - pathology | Administration, Intravenous | Animals | Angioedema - blood | Factor XII - metabolism | Thrombolytic Therapy | Angioedema - chemically induced | Thrombosis - genetics | Mice | Thrombosis - drug therapy | Index Medicus | Abridged Index Medicus | Thrombosis and Hemostasis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights